Home › Autoimmune Diseases › Texas › Fort Worth
Autoimmune Diseases clinical trials in Fort Worth, TX
3 studies for Autoimmune Diseases are looking for participants at sites in and around Fort Worth (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
RecruitingPhase 1
- UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
RecruitingPhase 3
- Cook Children's Medical Center, Fort Worth
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RecruitingObservational study
- Cook Children's Hospital, Fort Worth
About Autoimmune Diseases
Autoimmune diseases are where your immune system attacks healthy cells in your body by mistake. Learn about the symptoms, tests, and treatments.
More about Autoimmune Diseases on MedlinePlus
Autoimmune Diseases trials in other cities
- Houston, TX21 studies
- Washington, DC19 studies
- New York City, NY19 studies
- Philadelphia, PA16 studies
- Durham, NC15 studies
- Boston, MA13 studies
- Chicago, IL12 studies
- Los Angeles, CA12 studies
- Dallas, TX9 studies
- Atlanta, GA8 studies
- Portland, OR8 studies
- Milwaukee, WI8 studies
Other studies in Fort Worth
- Non-Small Cell Lung Cancer18 studies
- Ovarian Cancer17 studies
- Endometrial Cancer12 studies
- Breast Cancer12 studies
- Cancer (all types)9 studies
- Prostate Cancer9 studies
- Triple-Negative Breast Cancer7 studies
- Macular Degeneration7 studies
- Ulcerative Colitis7 studies
- Kidney Cancer (Renal Cell Carcinoma)7 studies
- Heart Failure7 studies
- Metastatic Cancer7 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.